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PH Domain Mutation Alters Membrane Targeting Specificity of GRP1
and AKT
Carissa Pilling.
University of Colorado Boulder, Boulder, CO, USA.
Protein kinase B (AKT1) and General Receptor for Phosphoinositides 1
(GRP1) regulate multiple cell signaling pathways essential for cell function
and survival. AKT1 possesses an N-terminal PH domain (AKT1-PH) that binds
important target phosphatidylinositol phospholipids (PIPs) such as PI(3,4)P3
and especially PI(3,4,5)P3. During a signaling event, PI(4,5)P2 gets converted
to PI(3,4,5)P3, resulting in targeting of AKT1 to the cell plasma membrane by
its PH domain. Our recent published work (Landgraf (2008) Biochemistry) re-
vealed that the E17K charge reversal mutation adjacent to the PIP binding site
in AKT1-PH alters the PIP specificity of the site, yielding high affinity binding
to PI(4,5)P2 and constitutive binding to plasma membrane. The resulting hy-
per-activation of AKT1 inhibits apoptosis and explains the known oncogenic
character of the E17K mutation, which is linked to multiple human cancers.
Here we test the hypothesis that glutamate residues often found adjacent to
the PIP binding sites of PI(3,4,5)P3 -specific PH domains are essential to PIP
lipid specificity. Using a combination of biochemical, structural, and cell biol-
ogy approaches, we compare the PIP lipid specificities and intracellular target-
ing of GRP1-PH and E345K-GRP1-PH. The latter mutant possesses a charge
reversal mutation at a glutamate position adjacent to the PIP binding site.
The preliminary findings, which will be presented at the meeting, indicate
that the mutant exhibits high affinity binding to PI(4,5)P2 and constitutive bind-
ing to plasma membrane. These findings support the hypothesis that the adja-
cent glutamate residue plays an essential role in PI(3,4,5)P3 -specificity and
PI(3,4,5)P3 -regulated plasma membrane targeting in cells. Finally, we are in-
vestigating the structural basis for the specificity change by attempting to solve
the crystal structures of the E17K-GRP1-PH and E345K-GRP1-PH mutants
bound to PI(4,5)P2.
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Engineered Nanolipoproteins as Biosynthetic Decoys for Pathogen-
Binding
Atul N. Parikh, Daniel Bricarello, Emily J. Mills, Jitka Petrlova, John Voss.
University of California, UC Davis, CA, USA.
The ability to exogenously present cell-surface receptors in a synthetic system
offers an opportunity to provide host cells with protection from pathogenic
toxins. Practical implementations suffer from serious limitations, primarily be-
cause of difficulties in mimicking the role of the membrane micro-environment
during the complex and dynamic pathogen-receptor interaction. To this end, we
have developed reconstituted lipoprotein - nanometer-sized discoidal lipid bi-
layers of arbitrary composition bounded by apolipoprotein - to serve as a versa-
tile, biocompatible and stable platform to house pathogen-binding receptors in
a membrane-like environment. Our approach exploits the notion that a control
of biophysical properties of the membrane micro-environment allows to mod-
ulate interactions between membrane-embedded receptors and their pathogenic
(e.g., bacterial toxin) targets. We demonstrate here, using a Foerster Resonance
Energy Transfer (FRET) based assay, that ganglioside GM1 receptors incorpo-
rated at controlled concentrations in reconstituted lipoprotein bind cholera
toxin with greater affinity than liposome-based systems. Furthermore, fluores-
cence microscopy investigations of cholera toxin presented to populations of
mammalian cells show that GM1-laden lipoprotein can function as decoys
without harming healthy cells.
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Calcium carbonate is often used as an efficient antacid that absorbs and neutral-
izes stomach acid while providing calcium for healthy bones. Taking advantage
of the lack of adverse side effects of calcium, new drug delivery systems con-
sisting of drug-supported spherical microparticles are being developed. We
have reported in our previous studies that a natural process producing calcium
carbonate microparticles can be found during avian development. These naturalsystems provide inspiration for designing more efficient microparticle facili-
tated drug-delivery systems. In this study, the formation and re-absorption of
calcium carbonate crystals were tracked during Gallina N. meleagris embryo-
genesis and early postnatal development. The study demonstrated that the for-
mation of calcium carbonate microparticles, as calcium is transferred from the
eggshell into the egg sac, is a process of calcium preservation. X-ray diffraction
showed that calcium carbonate crystal is mainly preserved in the vaterite iso-
form. Calcium incorporated into the yolk sac during this process can be easily
assimilated as necessary during postnatal development. Eons of evolution have
yielded a calcium preservation process that produces an iso-form of crystalline
calcium most readily absorbed by the organism. Our previous results indicate
that this biological system is likely a lyotropic process, the method that is cur-
rently being used for the production of microparticle drug delivery systems. In
this work, our data suggests that calcium carbonate crystal can also initiate its
crystallization from the center of liquid crystal, recognizable by a chimeric
thermal phase transition. Our work provides valuable information for designing
more efficient microparticle for drug-delivery.
Voltage-gated Ca Channels II
3603-Pos
Stim1 Binds to and Inhibits CaV1.2 Voltage Gated Calcium Channels
Chan Young Park, Aleksandr Shcheglovitov, Ricardo E. Dolmetsch.
Stanford, Palo Alto, CA, USA.
CaV1.2 and other L-type voltage gated calcium channels play a key role in reg-
ulating cardiac contraction, synaptic plasticity, insulin secretion and a variety
of other cellular events. Phospho-inositide linked receptors like the muscarinic
acetylcholine receptor, inhibit L-type calcium channels and this inhibition is
important for parasympathetic regulation of heart contraction as well as for
learning and memory in the brain. The mechanisms by which PLC coupled re-
ceptors inhibit L-type channels are still controversial though several hypotheses
including reduction of cAMP and depletion of PIP2 from the cell membrane
have been proposed. We report a new and unexpected mechanism by which
PLC-coupled receptors inhibit L-type calcium channels in cells. We have found
that depletion of ER calcium stores either down stream of muscarinic receptors
or following application of the ER calcium ATPase inhibitor, thapsigargin, in-
hibits CaV1.2 channels. CaV1.2 inhibition depends on binding to Stim1, an ER
calcium sensor protein that activates the Orai family of store operated calcium
channels. In cells expressing CaV1.2, Stim1 translocates to ER-plasma mem-
brane junctions and co-localizes with clusters of CaV1.2. In vitro and in vivo
studies indicate that the CAD domain of Stim1 binds to a coiled coil in the
II-III loop of CaV1.2. Stim1 lacking the CAD domain is unable to bind to
CaV1.2 and fails to inhibit CaV1.2 currents following depletion of ER calcium
stores. These studies support a new mechanism by which phosphoinositide-
linked receptors inhibit L-type calcium channels and suggest that Stim1 dy-
namically regulates the relative contributions of Orai and CaV1.2 channels to
calcium influx in excitable cells.
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Oxygen-Sensing of L-type Calcium Channels in Rat Cardiomyocytes: The
Possible Role of Hemoxygenase
Angelo O. Rosa, Lars Cleemann, Martin Morad.
Cardiac Signaling Center, MUSC, USC and Clemson University, Charleston,
SC, USA.
Hemoxygenases (HO)-1 and 2 are enzymes that metabolize the heme group,
generating CO, biliverdin and Feþ2. HO-2 is believed to be an O2 sensor in the
carotid body controlling the release of dopamine as it needs O2 for its function.
HO-2 is necessary for the anoxic activation of nociceptive neuron and binds to
calmodulin in neurons, and the complex is modulated by Ca2þ. Previously, we
have found that L-type Ca2þ channel is suppressed by 22-43% with acute an-
oxia prior to metabolic impairment or run down of Ica . This property appeared
to require the calmodulin-binding IQ motif on the cytoplasmic carboxy-tail of
the channel. Here we probe whether HO mediates this rapid Ica-suppressant ef-
fect of anoxia thus serving as the O2 sensor of the heart. Freshly isolated rat
cardiomyocites were maintained in Tyrode containing (in mM): 135NaCl,
5.4KCl, 10Hepes, 10glucose, 1MgCl2 and 2CaCl2). Internal solution used
was (in mM): 15NaCl, 118CsCl, 5.5Glucose, 14EGTA, 3.92CaCl2, 10Hepes,
3MgATP, 0.5MgCl2. Solutions bubbled with 100% O2 or 100% N2 were rap-
idly (50ms) applied. IBa was measured replacing CaCl2 for BaCl2. HO inhibi-
tors ZnPP-IX 100nM or SnPP-IX 100nM were added to either 100% O2 or
100% N2 solutions. Both the O2 removal and the inhibition of HO blocked
